Nathan Treybeck
Stock Analyst at Wells Fargo
(2.07)
# 3,001
Out of 5,148 analysts
27
Total ratings
35.29%
Success rate
2.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $51 → $34 | $25.90 | +31.27% | 10 | Feb 26, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $87 → $94 | $107.40 | -12.47% | 3 | Feb 26, 2026 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $225 → $200 | $128.46 | +55.69% | 7 | Feb 20, 2026 | |
| ITGR Integer Holdings | Maintains: Equal-Weight | $72 → $84 | $86.34 | -2.71% | 5 | Feb 20, 2026 | |
| RMD ResMed | Maintains: Equal-Weight | $265 → $270 | $257.39 | +4.90% | 2 | Jan 30, 2026 |
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Overweight
Price Target: $51 → $34
Current: $25.90
Upside: +31.27%
LeMaitre Vascular
Feb 26, 2026
Maintains: Equal-Weight
Price Target: $87 → $94
Current: $107.40
Upside: -12.47%
iRhythm Holdings
Feb 20, 2026
Maintains: Overweight
Price Target: $225 → $200
Current: $128.46
Upside: +55.69%
Integer Holdings
Feb 20, 2026
Maintains: Equal-Weight
Price Target: $72 → $84
Current: $86.34
Upside: -2.71%
ResMed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $265 → $270
Current: $257.39
Upside: +4.90%